LISAvienna: October newsletter highlights recent milestones

Today, we focus on OpGen subsidiary Ares Genetics, AOP Orphan, ImageBiopsy Lab, Valneva, Aposcience, Apeiron Biologics, BOKU, University of Vienna, Hookipa Pharma, Boehringer Ingelheim, Nabriva, Teledoc, Houska Prize, XUND and ÖGMBT.

In addition, we update you on upcoming events and funding opportunities and promote the new Vienna Life Science Report 2021/22.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)